City
Epaper

PrivacyShield Launches India's First "Consent Centre" - A Self-Service Privacy Portal for Individuals under DPDP Act 2023

By ANI | Updated: September 9, 2025 14:40 IST

VMPLPune (Maharashtra) [India], September 9: PrivacyShield, India's leading privacy management solution provider, today announced the launch of its ...

Open in App

VMPL

Pune (Maharashtra) [India], September 9: PrivacyShield, India's leading privacy management solution provider, today announced the launch of its groundbreaking feature, Consent Centre - a first-of-its-kind self-service portal designed to empower individuals and simplify compliance for organisations under the Digital Personal Data Protection Act (DPDP 2023).

Consent Centre is built to serve customers, vendors, employees, job applicants, website visitors, and event/webinar registrants whose personal data is collected by organizations. The portal provides individuals with:

* Transparency: A single window to view all personal data collected by the organization.

* Control: Access to consent history with the ability to withdraw or update consents.

* Rights Enablement: Secure authentication to raise and track Data Subject Access Requests (DSARs).

By enabling direct access to data and consent history, Consent Centre reduces the volume of DSAR requests, eliminates fraudulent claims, and helps organisations demonstrate accountability and compliance in line with DPDP requirements.

"India's DPDP Act has shifted the spotlight on transparency, accountability, and individual rights. Organisations can no longer wait for requests to come in - they must proactively enable individuals to understand and control how their data is used," said Debasish Pramanik, Co-Founder of PrivacyShield.

"Consent Centre is our answer to this challenge - a citizen-first, Make in India platform that not only reduces compliance burden but also builds trust at scale. We believe this is a defining moment for Indian enterprises to move from reactive compliance to proactive empowerment."

About PrivacyShield

PrivacyShield is a comprehensive privacy management solution developed for Indian organizations to comply with the Digital Personal Data Protection Act (DPDP 2023). Its modular platform includes Data Discovery, Consent Management, Data Subject Access Request (DSAR), Record of Processing Activities (RoPA), and Cookie Consent Management.

By combining AI-powered automation with deep regulatory expertise, PrivacyShield enables enterprises to transform compliance into a competitive advantage, build trust with stakeholders, and reduce risks of financial penalties and reputational damage.

For more information, visit: www.privacyshield.ai

(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL.will not be responsible in any way for the content of the same)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

MumbaiMumbai Traffic: Car Count Crosses 15 Lakh, Density Soars to 753 Per Km; Numbers Double in 13 Years

TechnologyIndian mutual fund industry’s AUM projected to surpass Rs 300 trillion by 2035

BusinessIndian mutual fund industry’s AUM projected to surpass Rs 300 trillion by 2035

NationalRahul Gandhi renews 'vote chori' charge during Germany visit, claims 'full-scale assault' on India's institutions

BusinessHazoor Multi Projects Ltd. Approves Allotment of 82.48 Lakh Shares Following Warrant Conversions; Strengthens Capital Base Ahead of New NHAI Contracts

Business Realted Stories

BusinessLulu Mall Bengaluru Ushers in Christmas with Magical Tree Lighting Ceremony Amidst Festive Chill

BusinessJJ Fintax Solutions Private Limited (JJTAX) Celebrates 6 Successful Years, Strengthens Its Position with One-Stop Solution App - Uniqey by JJ Tax

BusinessPharmed Foundation announces "KK Aurora Light of Hope Fund" to support respiratory care for patients with rare diseases

BusinessTrade deal crucial to deepen US-India economic ties: Keshap

BusinessJioHotstar's Pharma Makes Audiences Question the Pharmaceutical System